3132:TSEMACNICA HOLDINGS INC. Analysis
Data as of 2026-03-16 - not real-time
¥2,300.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Macnica Holdings is trading below its short‑term moving averages while the relative strength index signals oversold conditions, suggesting a potential bounce from the nearby support zone. The MACD histogram remains in bearish territory, indicating continued downside pressure, yet the market price sits well under the discounted cash‑flow fair‑value estimate, and its price‑to‑earnings multiple is notably lower than the industry average. The stock also offers an attractive dividend yield and enjoys stable trading volume, providing income appeal and liquidity.
Fundamentally, the company delivers solid revenue growth, healthy operating cash flow and a moderate debt profile, supporting its capacity to sustain payouts. With modest beta and a volatility profile that, while elevated, remains within manageable bounds, the overall risk picture is balanced, making the current price a compelling entry point for investors seeking both value and dividend income.
Fundamentally, the company delivers solid revenue growth, healthy operating cash flow and a moderate debt profile, supporting its capacity to sustain payouts. With modest beta and a volatility profile that, while elevated, remains within manageable bounds, the overall risk picture is balanced, making the current price a compelling entry point for investors seeking both value and dividend income.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- oversold momentum indicator
- price near support level
- attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- valuation gap to discounted cash‑flow estimate
- strong revenue growth trajectory
- moderate payout ratio supporting dividend sustainability
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- consistent cash flow generation
- stable capital structure with manageable debt
- ongoing dividend income combined with upside valuation potential
Key Metrics & Analysis
Financial Health
Revenue Growth19.00%
Profit Margin1.84%
P/E Ratio19.5
ROE7.95%
ROA3.53%
Debt/Equity25.67
P/B Ratio1.5
Op. Cash Flow¥25.3B
Free Cash Flow¥16.8B
Industry P/E33.7
Technical Analysis
TrendNeutral
RSI35.8
Support¥2,216.00
Resistance¥2,823.00
MA 20¥2,541.23
MA 50¥2,546.39
MA 200¥2,207.82
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Fair Value¥2,655.46
GradeUndervalued
TypeBlend
Dividend Yield3.06%
Risk Assessment
Beta0.82
Volatility49.82%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.